Acute Porphyria Drug Database

Monograph

A10BF01 - Acarbose
Not porphyrinogenic
NP

Rationale
Carbohydrate, insignificant systemic exposure. .
Chemical description
Pseudotetrasaccharide, alpha- glucoidase inhibitor, peroral antidiabetic. Only 1-2 % absorbed from the intestines, the rest broken down by intestinal bacteria.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes A10B / A10BF or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Glucobay · Glucobay 50 mg, tabletten
United Kingdom
Acarbose · Acarbose 100mg tablets · Acarbose 50mg tablets · Glucobay · Glucobay 100mg tablets · Glucobay 50mg tablets
Norway
Acarbose al · Glucobay
Poland
Acarbose Aurovitas · Adeksa · Glucobay 100 · Glucobay 50
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙